Treatment Satisfaction Questionnaire for Medication

Waleed Sweileh's picture

Differences in Medication Adherence, Satisfaction and Clinical Symptoms in Schizophrenic outpatients Taking Different Antipsychotic Regimens

Journal Title, Volume, Page: 
Curr Drug Saf., 6(5):285-90
Year of Publication: 
2011
Authors: 
W M Sweileh
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Current Affiliation: 
College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
M S Ihbesheh
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
I S Jarar
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
A F Sawalha
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
A S Abu Taha
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
S H Zyoud
Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

OBJECTIVE:

To investigate differences in medication adherence, treatment satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic treatment regimens.

METHODOLOGY:

Medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8) while treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Psychiatric symptoms were measured using the 24-item expanded Brief Psychiatric Rating Scale (BPRS-E). Data were entered and analyzed using SPSS 16 for windows.

RESULTS:

A convenience sample of 131 schizophrenic patients was studied. Patients belonged to 7 groups based on their antipsychotic treatment regimens. There was no significant difference in the means of adherence (P=0.6) and BPRS domains: positive (P=0.6), negative (P=0.8), manic (P=0.2) and depression (P=0.9) scores among the studied groups. Satisfaction with side effect domain was significantly different among studied groups (P=0.006, F=3). However, no significant difference was found in other satisfaction domains: effectiveness (P=0.8), convenience (P=0.3), and global satisfaction (P=0.8).

CONCLUSIONS:

Medications adherence, most treatment satisfaction domains and clinical symptom scores were not significantly different among patients taking different antipsychotic regimens.

ansam's picture

Differences in Medication Adherence, Satisfaction and Clinical Symptoms in Schizophrenic Outpatients Taking Different Antipsychotic Regimens

Journal Title, Volume, Page: 
Current Drug Safety, 6(5), 285-290
Year of Publication: 
2011
Authors: 
Ansam F. Sawalha
Department of Pharmacology and Toxicology, School of Pharmacy, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Faculty of Medicine & Health Sciences, Department of Biomedical Sciences, An-Najah National University, Nablus, Palestine
Waleed M. Sweileh
Department of Pharmacology and Toxicology, School of Pharmacy, An-Najah National University, Nablus, Palestine
Manal S. Ihbesheh
School of Pharmacy, Department of Biochemistry, An-Najah National University, Nablus, Palestine
Ikhlas S. Jarar
Department of Pharmacology and Toxicology, School of Pharmacy, An-Najah National University, Nablus, Palestine
Adham S. Abu Taha
Department of Pharmacology and Toxicology, School of Pharmacy, An-Najah National University, Nablus, Palestine
Sa'ed H. Zyoud
WHO Collaborating Centre for Drug Information, National Poison Centre, Universiti Sains Malaysia (USM), 11800 Penang, Malaysia
Donald E. Morisky
Department of Community Health Sciences UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772, USA
Preferred Abstract (Original): 
Objective
To investigate differences in medication adherence, treatment satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic treatment regimens.
Methodology
Medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8) while treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Psychiatric symptoms were measured using the 24-item expanded Brief Psychiatric Rating Scale (BPRS-E). Data were entered and analyzed using SPSS 16 for windows.
Resuls
A convenience sample of 131 schizophrenic patients was studied. Patients belonged to 7 groups based on their antipsychotic treatment regimens. There was no significant difference in the means of adherence (P=0.6) and BPRS domains: positive (P=0.6), negative (P=0.8), manic (P=0.2) and depression (P=0.9) scores among the studied groups. Satisfaction with side effect domain was significantly different among studied groups (P=0.006, F=3). However, no significant difference was found in other satisfaction domains: effectiveness (P=0.8), convenience (P=0.3), and global satisfaction (P=0.8).
Conclusions
Medications adherence, most treatment satisfaction domains and clinical symptom scores were not significantly different among patients taking different antipsychotic regimens.
Manal Ihbeasheh's picture

Differences in Medication Adherence, Satisfaction and Clinical Symptoms in Schizophrenic ‎Outpatients Taking Different Antipsychotic Regimens

Journal Title, Volume, Page: 
current drug safety . 2011 Nov 1;6(5):285-90.
Year of Publication: 
2011
Authors: 
Manal S. Ihbesheh
Department of Biochemistry, College of Pharmacy, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Faculty of Medicine & Health Sciences, Department of Biomedical Sciences, An-Najah National University, Nablus, Palestine
Waleed M. Sweileh
Department of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine
Ikhlas S. Jarar
Department of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine
Ansam F. Sawalha
Department of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine
Adham S. Abu Taha
Department of Pharmacology and Toxicology, College of Pharmacy, An-Najah National University, Nablus, Palestine
Sa'ed H. Zyoud
WHO Collaborating Centre for Drug Information, National Poison Centre, Universiti Sains Malaysia (USM), Penang, Malaysia
Donald E. Moriskyd
Department of Community Health Sciences UCLA School of Public Health, Los Angeles, CA, USA
Preferred Abstract (Original): 
Abstract: Objective: To investigate differences in medication adherence, treatment satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic treatment regimens. Methodology: Medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8) while treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Psychiatric symptoms were measured using the 24-item expanded Brief Psychiatric Rating Scale (BPRS-E). Data were entered and analyzed using SPSS 16 for windows. Results: A convenience sample of 131 schizophrenic patients was studied. Patients belonged to 7 groups based on their antipsychotic treatment regimens. There was no significant difference in the means of adherence (P=0.6) and BPRS domains: positive (P=0.6), negative (P=0.8), manic (P=0.2) and depression (P=0.9) scores among the studied groups. Satisfaction with side effect domain was significantly different among studied groups (P=0.006, F=3). However, no significant difference was found in other satisfaction domains: effectiveness (P=0.8), convenience (P=0.3), and global satisfaction (P=0.8). Conclusions: Medications adherence, most treatment satisfaction domains and clinical symptom scores were not significantly different among patients taking different antipsychotic regimens.
saedzyoud's picture

Differences in Medication Adherence, Satisfaction and Clinical Symptoms in Schizophrenic Outpatients Taking Different Antipsychotic Regimens

Journal Title, Volume, Page: 
Current Drug Safety 2011 Nov 1;6(5):285-90
Year of Publication: 
2011
Authors: 
Sweileh WM
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Ihbesheh MS
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Jarar IS
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Sawalha AF
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Zyoud SH
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Morisky DE
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

OBJECTIVE: To investigate differences in medication adherence, treatment satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic treatment regimens.
METHODOLOGY: Medication adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8) while treatment satisfaction was measured using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Psychiatric symptoms were measured using the 24-item expanded Brief Psychiatric Rating Scale (BPRS-E). Data were entered and analyzed using SPSS 16 for windows.
RESULTS: A convenience sample of 131 schizophrenic patients was studied. Patients belonged to 7 groups based on their antipsychotic treatment regimens. There was no significant difference in the means of adherence (P=0.6) and BPRS domains: positive (P=0.6), negative (P=0.8), manic (P=0.2) and depression (P=0.9) scores among the studied groups. Satisfaction with side effect domain was significantly different among studied groups (P=0.006, F=3). However, no significant difference was found in other satisfaction domains: effectiveness (P=0.8), convenience (P=0.3), and global satisfaction (P=0.8).
CONCLUSIONS: Medications adherence, most treatment satisfaction domains and clinical symptom scores were not significantly different among patients taking different antipsychotic regimens.

Syndicate content